NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
+5.94%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$2.13B
AUM Growth
+$2.13B
Cap. Flow
-$33.6M
Cap. Flow %
-1.57%
Top 10 Hldgs %
71.72%
Holding
45
New
2
Increased
3
Reduced
1
Closed
2

Top Buys

1
SURF
Surface Oncology, Inc. Common Stock
SURF
$54.1M
2
MEIP icon
MEI Pharma
MEIP
$22.5M
3
CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
$8.14M
4
ARDX icon
Ardelyx
ARDX
$4.63M
5
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
$3.2M

Top Sells

1
CRSP icon
CRISPR Therapeutics
CRSP
$81.9M
2
IMMU
Immunomedics Inc
IMMU
$40.5M
3
AQ
Aquantia Corp. Common Stock
AQ
$3.76M

Sector Composition

1 Healthcare 88.57%
2 Technology 6.79%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$463M 21.71% 10,420,555 – –
ADAP
2
Adaptimmune Therapeutics
ADAP
$15.6M
$158M 7.41% 13,332,611 – –
RYTM icon
3
Rhythm Pharmaceuticals
RYTM
$6.85B
$154M 7.19% 4,912,306 – –
CBIO
4
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$147M 6.87% 9,089,041 +504,913 +6% +$8.14M
MRSN icon
5
Mersana Therapeutics
MRSN
$36.5M
$145M 6.81% 8,144,267 – –
SENS icon
6
Senseonics Holdings
SENS
$374M
$127M 5.95% 30,888,266 – –
CRSP icon
7
CRISPR Therapeutics
CRSP
$4.71B
$123M 5.76% 2,090,678 -1,393,786 -40% -$81.9M
EPZM
8
DELISTED
Epizyme, Inc
EPZM
$87.5M 4.1% 6,460,851 – –
OBSV
9
DELISTED
ObsEva SA Ordinary Shares
OBSV
$69.4M 3.25% 4,586,563 – –
ARDX icon
10
Ardelyx
ARDX
$1.53B
$56.7M 2.66% 15,335,047 +1,251,465 +9% +$4.63M
RARX
11
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$54.7M 2.56% 5,493,636 – –
SURF
12
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$54.1M 2.53% +3,315,149 New +$54.1M
AKAO
13
DELISTED
Achaogen, Inc.
AKAO
$45.2M 2.12% 5,215,128 – –
SYBX icon
14
Synlogic
SYBX
$17M
$41.6M 1.95% 4,229,410 – –
AVEO
15
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$40.1M 1.88% 17,783,722 +1,421,028 +9% +$3.2M
DERM
16
DELISTED
Dermira, Inc.
DERM
$32.3M 1.51% 3,506,649 – –
LXRX icon
17
Lexicon Pharmaceuticals
LXRX
$400M
$28.6M 1.34% 2,382,286 – –
CMTA
18
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$28.2M 1.32% 2,141,697 – –
AUPH icon
19
Aurinia Pharmaceuticals
AUPH
$1.58B
$27.1M 1.27% 4,808,483 – –
SBBP
20
DELISTED
Strongbridge Biopharma plc.
SBBP
$24.8M 1.16% 4,141,308 – –
MEIP icon
21
MEI Pharma
MEIP
$160M
$22.5M 1.06% +5,720,572 New +$22.5M
GNCA
22
DELISTED
Genocea Biosciences, Inc.
GNCA
$21.3M 1% 25,000,000 – –
CTIC
23
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$18.7M 0.87% 3,750,000 – –
VRNA
24
Verona Pharma
VRNA
$9.16B
$16.7M 0.78% 1,219,674 – –
KA
25
DELISTED
Kineta, Inc. Common Stock
KA
$15.5M 0.73% 5,556,778 – –
1
2